New antipsychotic strategies: quetiapine and risperidone vs. fluphenazine in treatment resistant schizophrenia

Trial Profile

New antipsychotic strategies: quetiapine and risperidone vs. fluphenazine in treatment resistant schizophrenia

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2008

At a glance

  • Drugs Quetiapine (Primary) ; Risperidone (Primary) ; Fluphenazine
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2008 Status changed from active, no longer recruiting to completed.
    • 04 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top